Dermatology Imaging Market Size, Share & Trends Analysis Report by Imaging Modality (Digital photographic imaging, Dermoscopy), By Application (Pigmented Lesions, Skin Cancer), By End-use, By Region, And Segment Forecasts, 2022 To 2030

Market Synopsis

The visual nature of dermatology has made imaging techniques a highly essential part of assessing and treating cutaneous diseases. Imaging is mainly used for documenting conditions, monitoring high-risk patients, communicating and academics. Augmentation of improved quality and portable device, have taken advanced dermatology to the next level. Digital photographic imaging uses handheld cameras and smartphones, that provides high-resolution images and enables dermatologists to effortlessly capture and document the state of the patient’s skin condition or lesion in a magnitude of settings. With the rise in skin cancer, there is a huge need for more advanced and improved techniques. For instance, in the U.S., on a daily basis, nearly 9,500 people get diagnosed with skin cancer and ~3 million are affected by basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), annually.

It is also estimated that invasive melanoma would be the fifth most commonly diagnosed cancer for both men (57,180 cases) and women (42,600 cases) in 2022. (Source: American Academy of Dermatology Association). This calls for increased diagnostic accuracy, time-efficient, and reduces unnecessary biopsies. New emerging technologies include confocal microscopy, optical coherence tomography, high-frequency ultrasound, Raman spectroscopy, and fluorescence imaging, which may be integrated into clinical practice to aid in patient diagnosis and management.

        Dermatology Imaging Market Segmentation

Market Influencer

The accuracy in the clinical diagnosis of cutaneous melanoma with the unaided eye is only ~60%. Thus, the use of digital photography imaging helps in efficiently examining and documenting changing lesions. This ensures the reduction of unnecessary biopsy tests and saves up to USD 70 million. On the other hand, dermoscopy is an in vivo technique for the microscopic examination of pigmented skin lesions, and has the potential to improve diagnostic accuracy. The use of non-invasive methods to diagnose and treat skin conditions has been increasingly popular in recent years, yet noninvasive dermatological tools come in a variety of forms. Dermatologists and other healthcare professionals frequently use dermoscopy, which offers inexpensive imaging of the skin's surface to assist in clinical diagnosis.

Reflectance confocal microscopy (RCM) offers reimbursable in vivo imaging of live tissue with the cellular-level resolution, but it is constrained by depth, expense, and the requirement for advanced training; as a result, RCM has only been utilized in a few clinical settings. In vivo imaging of live tissue is possible using optical coherence tomography, but it has a number of drawbacks, including poor resolution, high cost, the requirement for advanced training, and infrequent provider reimbursement. Future directions include expanding clinical practise and combining complementing imaging modalities. Despite the numerous advancements in dermatology imaging techniques, the high cost of equipment and the lack of dermatologist skills to operate the technology are barriers for their adoption.

The key players operating in the dermatology imaging market include Navitar, E-consystems, Caliberid, Emage Medical LLC, Courage + Khazaka electronic GmbH, Atys Medical, Longport Inc., Cortex Technology, Canfield Scientific, Inc., tpm – taberna pro medicum GmbH, MetaOptima Technology Inc., and DermSpectra.